Justin D. Gover - 10 Aug 2023 Form 4 Insider Report for Xenon Pharmaceuticals Inc. (XENE)

Role
Director
Signature
/s/ Cassandra Robinson, Attorney-in-fact
Issuer symbol
XENE
Transactions as of
10 Aug 2023
Net transactions value
$0
Form type
4
Filing time
10 Aug 2023, 19:05:25 UTC
Previous filing
10 Aug 2023
Next filing
05 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XENE Stock Option (Right to Buy) Award $0 +28,000 $0.000000 28,000 10 Aug 2023 Common Shares 28,000 $38.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the total shares subject to the Option shall vest on the first anniversary of August 8, 2023 (the "Start Date"), one-third on the second anniversary of the Start Date and the balance on the third anniversary of the Start Date.